BorrĂ¡s, Teresa
Cowley, Dale O.
Asokan, Priyadarsini
Pandya, Kumar
Funding for this research was provided by:
National Institutes of Health (EY11906 (TB), EY026220 (TB), EY030608 (TB), P30 CA016086 (DOC))
Article History
Received: 26 April 2020
Accepted: 9 October 2020
First Online: 29 October 2020
Competing interests
: D. O. Cowley. DOC is employed by, has equity ownership in and serves on the board of directors of TransViragen, the company which has been contracted by UNC-Chapel Hill to manage its Animal Models Core Facility. The other authors declare no competing interests.